Join EveryCat’s “Let’s Get CATletic” Virtual 5k Fundraiser Run May 1-31, 2022! Get registered now,  individually or as a team,  and start fundraising early! Help support feline health studies. For more information, click HERE

Grants

W14-015: Evaluating the cardiovascular effects of a potential new drug, MK-476, in combination with dexmedetomidine for sedation or pre-anesthesia

Dexmedetomidine is a drug commonly used in cats for its calming and pain‐relieving effects. It is also sometimes used prior to general anesthesia. However, its use is mostly indicated in relatively young, healthy cats, because it produces severe effects on the cardiovascular system. MK-467 is a drug that is expected to prevent the most important of these cardiovascular effects, while preserving the beneficial effects of dexmedetomidine when administered simultaneously. It has been studied in dogs and sheep, but not in cats. The goal is to determine if MK-467 offers a clinically attractive solution with limited negative effects while increasing the tolerance of dexmedetomidine in cats.

Grant ID: W14-015

Status: Active

Year Funded: 2014

Amount awarded: $17,083

Investigator: Bruno Pypendop;University of California-Davis